Norris Perne & French LLP Merck & Co., Inc. Transaction History

Norris Perne & French LLP

  • $1.36 Billion
  • Q3 2024

A detailed history of Norris Perne & French LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Norris Perne & French LLP holds 254,887 shares of MRK stock, worth $26.3 Million. This represents 2.13% of its overall portfolio holdings.

Number of Shares
254,887
Previous 203,029 25.54%
Holding current value
$26.3 Million
Previous $25.1 Million 15.16%
% of portfolio
2.13%
Previous 1.94%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
BUY
$111.15 - $128.97 $5.76 Million - $6.69 Million
51,858 Added 25.54%
254,887 $28.9 Million
Q2 2024

Jul 24, 2024
SELL
$123.8 - $132.96 $85,050 - $91,343
-687 Reduced 0.34%
203,029 $25.1 Million
Q1 2024

Apr 16, 2024
BUY
$113.24 - $131.95 $62,055 - $72,308
548 Added 0.27%
203,716 $26.9 Million
Q4 2023

Jan 22, 2024
BUY
$100.18 - $109.02 $2.95 Million - $3.21 Million
29,452 Added 16.95%
203,168 $22.1 Million
Q3 2023

Oct 18, 2023
BUY
$102.95 - $114.33 $190,251 - $211,281
1,848 Added 1.08%
173,716 $17.9 Million
Q2 2023

Jul 19, 2023
BUY
$108.61 - $118.38 $145,537 - $158,629
1,340 Added 0.79%
171,868 $19.8 Million
Q1 2023

Apr 20, 2023
SELL
$102.94 - $114.86 $131,248 - $146,446
-1,275 Reduced 0.74%
170,528 $18.1 Million
Q4 2022

Jan 24, 2023
BUY
$87.44 - $112.11 $39,785 - $51,010
455 Added 0.27%
171,803 $0
Q3 2022

Oct 13, 2022
SELL
$84.53 - $94.96 $5.95 Million - $6.69 Million
-70,408 Reduced 29.12%
171,348 $14.8 Million
Q2 2022

Aug 11, 2022
SELL
$83.49 - $94.64 $16,280 - $18,454
-195 Reduced 0.08%
241,756 $22 Million
Q1 2022

Apr 26, 2022
SELL
$73.51 - $82.4 $115,190 - $129,120
-1,567 Reduced 0.64%
241,951 $19.9 Million
Q4 2021

Jan 26, 2022
SELL
$72.28 - $90.54 $5.85 Million - $7.33 Million
-80,957 Reduced 24.95%
243,518 $18.7 Million
Q3 2021

Oct 26, 2021
BUY
$71.68 - $78.83 $628,633 - $691,339
8,770 Added 2.78%
324,475 $24.4 Million
Q2 2021

Jul 20, 2021
BUY
$70.31 - $77.77 $3.37 Million - $3.72 Million
47,872 Added 17.87%
315,705 $24.6 Million
Q1 2021

Apr 30, 2021
SELL
$68.86 - $81.11 $341,132 - $401,818
-4,954 Reduced 1.82%
267,833 $20.6 Million
Q4 2020

Jan 27, 2021
BUY
$71.77 - $79.65 $1.86 Million - $2.07 Million
25,948 Added 10.51%
272,787 $22.3 Million
Q3 2020

Oct 26, 2020
BUY
$73.18 - $82.95 $3.49 Million - $3.96 Million
47,717 Added 23.96%
246,839 $20.5 Million
Q2 2020

Jul 23, 2020
BUY
$70.42 - $80.13 $535,684 - $609,548
7,607 Added 3.97%
199,122 $15.4 Million
Q1 2020

Apr 16, 2020
BUY
$63.36 - $87.82 $2 Million - $2.77 Million
31,561 Added 19.73%
191,515 $14.7 Million
Q4 2019

Jan 22, 2020
BUY
$77.58 - $87.54 $11,016 - $12,430
142 Added 0.09%
159,954 $14.5 Million
Q3 2019

Oct 24, 2019
BUY
$76.08 - $82.93 $13,237 - $14,429
174 Added 0.11%
159,812 $13.5 Million
Q2 2019

Jul 19, 2019
BUY
$69.84 - $81.59 $10,545 - $12,320
151 Added 0.09%
159,638 $13.4 Million
Q1 2019

Apr 29, 2019
BUY
$69.58 - $79.36 $328,904 - $375,134
4,727 Added 3.05%
159,487 $13.3 Million
Q4 2018

Jan 28, 2019
BUY
$65.24 - $75.71 $112,669 - $130,751
1,727 Added 1.13%
154,760 $11.8 Million
Q3 2018

Oct 29, 2018
BUY
$57.69 - $67.84 $552,093 - $649,228
9,570 Added 6.67%
153,033 $10.9 Million
Q2 2018

Jul 24, 2018
BUY
$50.83 - $59.72 $382,902 - $449,870
7,533 Added 5.54%
143,463 $8.71 Million
Q1 2018

Apr 17, 2018
SELL
$50.96 - $59.23 $25,480 - $29,615
-500 Reduced 0.37%
135,930 $7.4 Million
Q4 2017

Jan 23, 2018
SELL
$51.62 - $61.64 $130,753 - $156,134
-2,533 Reduced 1.82%
136,430 $7.68 Million
Q3 2017

Nov 01, 2017
BUY
$58.67 - $63.13 $8.15 Million - $8.77 Million
138,963
138,963 $8.9 Million

Others Institutions Holding MRK

# of Institutions
3,824
Shares Held
1.88B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Norris Perne & French LLP Portfolio

Follow Norris Perne & French LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email